Last reviewed · How we verify

NCT06139432: CATATOES

Catatonia: Effectiveness of Transcranial Direct Current Electrostimulation (CATATOES)

Status unknown NA Last updated 24 November 2023
What this trial tests

NA trial testing Active tDCS in Catatonia in 70 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorCentre Hospitalier St Anne
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment70
Start date1 December 2023
Primary completion31 December 2025
Estimated completion31 December 2025
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier St Anne

Who can join

18 and older, any sex, with Catatonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nearly 10% of people hospitalized in psychiatry have a catatonic syndrome. The treatment of this syndrome is based on lorazepam and electro-convulsive therapy (ECT) in drug-resistant forms. ECT is the reference therapy, very effective in catatonia, but remain difficult to access due to the technical platform required for their realization, leading to delays in the implementation of the treatment responsible for an increase in the morbidity and mortality of catatonia. In this context, a new therapeutic tool available in the treatment of drug-resistant catatonia would improve the prognosis of catatonia. Transcranial direct current stimulation (tDCS) is an alternative, non-invasive brain stimulation technique that does not require anesthesia, and inexpensive and has been shown to be effective in depression and schizophrenia. A series of clinical cases suggests its potential efficacy in catatonia. Our objective is to evaluate the efficacy of tDCS in catatonia in a clinical trial.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Moving to accelerated protocols of tDCS in catatonia: a case report.
    Bouaziz N, Luisada JC, Jabri S, Andrianisaina PS, et al · · 2023 · cited 6× · PMID 38188043 · DOI 10.3389/fpsyt.2023.1302718
  2. CATATOnia treatment with transcranial direct current electrostimulation: protocol of a randomised, double-blind, placebo-controlled bicentric superiority study (CATATOES).
    Moyal M, Attali D, Berre AL, Bouaziz N, et al · · 2025 · PMID 41062970 · DOI 10.1186/s12888-025-07266-5
  3. CATATOnia treatment with transcranial direct current ElectroStimulation: protocol of a randomised, double-blind, placebo-controlled bicentric superiority study (CATATOES)
    Moyal M, Attali D, Berre AL, Bouaziz N, et al · · 2024 · DOI 10.21203/rs.3.rs-5355181/v1

Verify or expand the search:

Other trials of Active tDCS

Trials testing the same drug.

Other recruiting trials for Catatonia

Currently open trials in the same condition.

Other Centre Hospitalier St Anne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06139432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing